Institutions / Velan Capital Investment Management LP
Velan Capital Investment Management LP
CIK 1848809 · Institution · as of Dec 31, 2025
Portfolio value
$171.90M
Positions
45
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 45 →
| Company | Value | % of portfolio |
|---|---|---|
| Praxis Precision Medicines, Inc. | $29.70M | 17.3% |
| Cidara Therapeutics Inc | $23.95M | 13.9% |
| Protara Therapeutics, Inc. | $15.11M | 8.8% |
| Heron Therapeutics, Inc. /De | $11.38M | 6.6% |
| Maplight Therapeutics IncMPLT | $9.17M | 5.3% |
| Abivax SA | $9.04M | 5.3% |
| Evommune, Inc.EVMN | $8.68M | 5.0% |
| Mineralys Therapeutics IncMLYS | $5.48M | 3.2% |
| Lantheus Holdings, Inc. | $4.97M | 2.9% |
| Jasper Therapeutics IncJSPR | $4.88M | 2.8% |
| Avalo Therapeutics, Inc. | $4.79M | 2.8% |
| Esperion Therapeutics, Inc. | $4.48M | 2.6% |
| Verrica Pharmaceuticals Inc.VRCA | $3.92M | 2.3% |
| InspireMD, Inc.NSPR | $3.82M | 2.2% |
| Rapt Therapeutics Inc | $3.66M | 2.1% |
| Sutro Biopharma, Inc. | $3.61M | 2.1% |
| Terns Pharmaceuticals, Inc. | $2.83M | 1.6% |
| Syndax Pharmaceuticals Inc | $2.73M | 1.6% |
| Viridian Therapeutics, Inc. | $2.69M | 1.6% |
| Eupraxia Pharmaceuticals Inc. | $2.66M | 1.5% |
| Trevi Therapeutics, Inc. | $2.57M | 1.5% |
| Profound Med Corp | $2.25M | 1.3% |
| Kazia Therapeutics LtdKZIA | $2.07M | 1.2% |
| Rezolute, Inc. | $1.77M | 1.0% |
| Tenax Therapeutics, Inc. | $1.02M | 0.6% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.